Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

CA033 entitled: “An Open-Label, Multicenter, Phase III Trial of ABI-007 vs. Dacarbazine in Previously Untreated Patients with Metastatic Malignant Mel


Collapse Overview 
Collapse sponsor award id
CA033


Collapse Biography 

Collapse Time 
Collapse start date
2010-08-02